Sanofi says FDA accepts filing for new diabetes drug Toujeo

PARIS, July 8 (Reuters) - Sanofi said on Tuesday the U.S. Food and Drug Administration had accepted for review the filing of a new drug application for its diabetes drug Toujeo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.